Searching journal content for endocrine therapy resistance (as phrase) in full text.

Displaying results 1-10 of 36

For checked items

view abstracts
download to citation manager

Select this article
Review:
- Tesa M Severson and
- Wilbert Zwart
A review of estrogen receptor/androgen receptor genomics in male breast cancer Endocr Relat Cancer 24 (3) R27-R34, doi:10.1530/ERC-16-0225 first published on 6 January 2017
...endocrine therapy resistance is clinically identified at the level of recurrent disease, a clear clinical need exists to identify markers for endocrine resistance at an early stage, so that patients with a predicted resistance can be treated with an alternative treatment instead. ERα and AR both hav ~~~
Select this article
Thematic Review:
- Isabel Coutinho,
- Tanya K Day,
- Wayne D Tilley,
- and Luke A Selth
Androgen receptor signaling in castration-resistant prostate cancer: a lesson in persistence Endocr Relat Cancer 23 (12) T179-T197, doi:10.1530/ERC-16-0422 first published on 31 October 2016
...endocrine therapy resistance f hormone structure/ function T180Thematic Review I Coutinho et al. Androgen receptor signaling in CRPC DOI: 10.1530/ERC-16-0422 http://.endocrinology-journals.org © 2016 Society for Endocrinology Printed in Great Britain Published by Bioscientifica Ltd. 23:12 an AR-inde ~~~
Select this article
Thematic Review:
- Patricia V Elizalde,
- Rosalía I Cordo Russo,
- Maria F Chervo,
- and Roxana Schillaci
ErbB-2 nuclear function in breast cancer growth, metastasis and resistance to therapy Endocr Relat Cancer 23 (12) T243-T257, doi:10.1530/ERC-16-0360 first published on 7 October 2016
...endocrine therapy resistance ~~~
Select this article
Thematic Review:
- Damien A Leach,
- Sue M Powell,
- and Charlotte L Bevan
WOMEN IN CANCER THEMATIC REVIEW: New roles for nuclear receptors in prostate cancer Endocr Relat Cancer 23 (11) T85-T108, doi:10.1530/ERC-16-0319 first published on 19 September 2016
...endocrine therapy resistance f estrogen receptor f gene transcription f prostate f coactivator f corepressor T86Thematic Review D A Leach et al. Nuclear receptors in prostate cancer DOI: 10.1530/ERC-16-0319 http://.endocrinology-journals.org © 2016 Society for Endocrinology Printed in Great Britain ~~~
Select this article
Research:
- Hyun Ho Han,
- Baek Gil Kim,
- Joo Hyun Lee,
- Suki Kang,
- Ji Eun Kim,
- and Nam Hoon Cho
Angiopoietin-2 promotes ER+ breast cancer cell survival in bone marrow niche Endocr Relat Cancer 23 (8) 609-623, doi:10.1530/ERC-16-0086 first published on 27 June 2016
...endocrine therapy resistance f cell signaling Open Access 610Research H H Han et al. Angiopoietin-2 drives dormant cancer reactivation DOI: 10.1530/ERC-16-0086 http://.endocrinology-journals.org © 2016 Society for Endocrinology Printed in Great Britain Published by Bioscientifica Ltd. 23:8 Zhang et ~~~
OPEN ACCESS ARTICLE
Select this article
Research:
- Milena Rondón-Lagos,
- Nelson Rangel,
- Ludovica Verdun Di Cantogno,
- Laura Annaratone,
- Isabella Castellano,
- Rosalia Russo,
- Tilde Manetta,
- Caterina Marchiò,
- and Anna Sapino
Effect of low doses of estradiol and tamoxifen on breast cancer cell karyotypes Endocr Relat Cancer 23 (8) 635-650, doi:10.1530/ERC-16-0078 first published on 29 June 2016
...endocrine therapy resistance (Johnston & Dowsett 2003). In addition, residual amounts of estrogen may still be present after treatment with aromatase inhibitors, which function by reducing estrogen biosynthesis (Dowsett Figure 4 Effects of E2 (A) and TAM (B) treatment for 24, 48, and 96 h on prolife ~~~
OPEN ACCESS ARTICLE
Select this article
Review:
- Conleth G Murphy and
- Maura N Dickler
Endocrine resistance in hormone-responsive breast cancer: mechanisms and therapeutic strategies Endocr Relat Cancer 23 (8) R337-R352, doi:10.1530/ERC-16-0121 first published on 12 July 2016
...endocrine therapy resistance f breast cancer Correspondence should be addressed to M N Dickler Email [email protected] R338Review C G Murphy and M N Dickler Advances in treatment for HR+ breast cancer DOI: 10.1530/ERC-16-0121 http://.endocrinology-journals.org © 2016 Society for Endocrinology Print ~~~
Select this article
Review:
- Jamie L Van Etten and
- Scott M Dehm
Clonal origin and spread of metastatic prostate cancer Endocr Relat Cancer 23 (4) R207-R217, doi:10.1530/ERC-16-0049 first published on 21 March 2016
...endocrine therapy resistance f cell lineage/genetics f clonal spread Abstract Metastatic disease is responsible for the majority of prostate cancer deaths. The standard treatment for metastatic disease is surgical or chemical castration in the form of androgen deprivation therapy. Despite initial su ~~~
Select this article
Review:
- M Bullock
FOXO factors and breast cancer: outfoxing endocrine resistance Endocr Relat Cancer 23 (2) R113-R130, doi:10.1530/ERC-15-0461 first published on 26 November 2015
...endocrine therapy resistance and is a therapeutic http://.endocrinology-journals.org q 2016 Society for Endocrinology DOI: 10.1530/ERC-15-0461 Printed in Great Britaintarget in breast cancer. Cancer Research 70 2085–2094. (doi:10.1158/ 0008-5472.CAN-09-3746) Tzahar E, Waterman H, Chen X, Levkowitz G ~~~
Select this article
Editorial:
- Dean G Tang
Cancers of the breast and prostate: a stem cell perspective Endocr Relat Cancer 22 (6) E9-E11, doi:10.1530/ERC-15-0427
...endocrine therapy resistance and metastasis. Unlike estrogen, progesterone seems to clearly promote the expansion of BCSCs, suggesting that anti-progesterone drugs may find clinical use in targeting BCSCs. Although the underlying mechanisms remain obscure, the BCSC-promoting effects of progesterone ~~~

For checked items

view abstracts
download to citation manager

Endocrine-Related Cancer

Searching journal content for endocrine therapy resistance (as phrase) in full text.

Search Results

Modify Results

This search

New Articles: issue in progress

Most

Viewed

Cited

Citation format:
Results / page:
Results order: